Results 141 to 150 of about 26,436 (212)

Combination therapy with Nifuroxazide and Lenvatinib exerts superior anti-hepatocellular carcinoma effect by enhancing the anti-tumor immune response. [PDF]

Front Oncol
Yang J, Geng J, Yin Y, Wang K, Tian L, Wang J, Jia H, Wang L, Zhang Y, Zhao T.   +9 more
europepmc   +1 more source

Efficacy of Lenvatinib versus Bevacizumab in Triple Therapy with Immune Checkpoint Inhibitors and Interventional Therapy for Hepatocellular Carcinoma with Macrovascular Invasion: A Multi-Center Real-World Retrospective Study. [PDF]

J Hepatocell Carcinoma
Zhang J, Liu Y, Ding Y, Deng Z, Jiang B, Gao B, Hu S, Sun J, Yang X, Zhang H, Li B.   +10 more
europepmc   +1 more source

Efficacy and safety of pembrolizumab-lenvatinib in metastatic endometrial cancer: results from the French multicenter early access program. [PDF]

ESMO Open
Bello Roufai D, Mansi L, Diallo MH, Fumet JD, Kalbacher E, Airoldi M, Cherifi F, Hanvic B, Auvray-Kuentz M, Billemont B, Gervais C, Batti R, Quesada S, Betrian-Lagarde S, Hardy-Bessard AC, Vegas H, Prulhiere-Corviole K, Muzellec L, Bouchaert P, Corbaux P, Chaix M, Collot T, Garbay-Decoopman D, Benderra MA, Kfoury M, Augereau P.   +25 more
europepmc   +1 more source

Case Report: Lenvatinib-induced lichenoid drug reaction mimicking disseminated zoster in a patient with metastatic hepatocellular carcinoma. [PDF]

Front Oncol
Kaufman M, Garcia-Santisteban R, Choi C, Merugu R, Kareff S.   +4 more
europepmc   +1 more source

Survival in unresectable hepatocellular carcinoma: Comparison of four treatments based on patients reconstructed from Kaplan-Meier curves of randomized trials. [PDF]

World J Gastrointest Pharmacol Ther
Damuzzo V, Vecchia S, Gasperoni L, Del Bono L, Ossato A, Orlandi E, Messori A.   +6 more
europepmc   +1 more source

DEB-TACE Combined with Immunotherapy and Targeted Therapy for Advanced Hepatocellular Carcinoma with Scapular Metastasis: A Case Report. [PDF]

J Hepatocell Carcinoma
Zhang W, Kang D, Xu Q, Piao L.
europepmc   +1 more source

A Phase Ib/IIa Study of Fostrox in Combination with Lenvatinib as Second-line Therapy in Patients with Advanced Hepatocellular Carcinoma. [PDF]

Clin Cancer Res
Chon HJ, Heo J, Kim DY, Lim HY, Macarulla T, Gomez Martín C, Moreno V, Reig M, Ryu MH, Yoon JH, Baumann P, Bhoi S, Jensen M, Tunblad K, Wallberg H, Öberg F, Evans TRJ.   +16 more
europepmc   +1 more source

Real-World Outcomes of Lenvatinib in Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Multicentre Retrospective Study. [PDF]

Cancers (Basel)
Chan WL, Tin WW, Wong KC, Kwok CC, Chow JCH, Liu TC, Cheung GT, Choi WY, Au LJ, To JC, Lo GY, Hou LY, Yeung KK, Leung HL, Kwong DL.   +14 more
europepmc   +1 more source

Recorded Early Imaging Responses After Transarterial Chemoembolization Plus Lenvatinib Versus Transarterial Chemoembolization Without Documented Lenvatinib for Unresectable Hepatocellular Carcinoma: A Vietnamese Cohort Study. [PDF]

J Clin Med
Minh VL, Hung NV, Anh PT, Anh PT, Thong PM.   +4 more
europepmc   +1 more source

The role and mechanism of CHST6-mediated lactation modification in lenvatinib resistance in hepatocellular carcinoma cells. [PDF]

Am J Transl Res
Wang D, Gao H, Li L.
europepmc   +1 more source